ALAS PROPIAS: Music Therapy for Women Experiencing Machista Violence in Intimate Partner Relationships
NCT07925723, Not applicable, Active not recruiting, Universidad Miguel Hernandez de Elche
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | ALAS PROPIAS: Music Therapy for Women Experiencing Machista Violence in Intimate Partner Relationships | ClinicalTrials.gov |
| NCT number | NCT07925723 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 67 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Universidad Miguel Hernandez de Elche | ClinicalTrials.gov |
| Conditions | Intimate Partner Violence (IPV), Intimate Partner Violence Against Women | ClinicalTrials.gov |
| Interventions | Experimental Group (ALAS PROPIAS) | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Self-Esteem | Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2) | Change in self-esteem from pre-test to post-test, measured using the Rosenberg Self-Esteem Scale in both the experimental group and the wait-list control group. | ClinicalTrials.gov |
| Primary | Change in Anxiety | Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2) | Change in anxiety from pre-test to post-test, measured using the State-Trait Anxiety Inventory (STAI) in both the experimental group and the wait-list control group. | ClinicalTrials.gov |
| Primary | Change in Depression | Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2) | Change in depression from pre-test to post-test, measured using the Beck Depression Inventory-II (BDI-II) in both the experimental group and the wait-list control group. | ClinicalTrials.gov |
| Primary | Change in Psychological Well-Being | Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2) | Change in psychological well-being from pre-test to post-test, measured using the Ryff Psychological Well-Being Scales in both the experimental group and the wait-list control group. | ClinicalTrials.gov |
| Primary | Change in Quality of Life | Baseline (T0), Immediate Post-intervention (T1), 3-month Follow-up (T2) | Change in quality of life from pre-test to post-test, measured using the GENCAT Quality of Life Scale in both the experimental group and the wait-list control group. | ClinicalTrials.gov |
| Primary | Changes in Mood-Related Indicators During the Music Therapy Intervention | At the beginning and end of each of the 12 music therapy sessions for the SAM; at the end of each session for the researcher's observational recording tool. | Changes in mood-related indicators are assessed in the experimental group throughout the 12-session group active music therapy intervention. The researcher uses a structured observational recording tool to document indicators associated with six emotional states: sadness, anger, shame, insecurity, fear, and happiness. The indicators include participants' verbal expressions, facial expressions, posture, vocal characteristics, participation in musical activities, and interactions with other group members. In addition, participants complete the Self-Assessment Manikin (SAM) at the beginning and end of each session to assess their momentary affective responses | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)